@FierceBiotech: Band of West Coast biotech insiders pushes oral anticoagulant to PhIII. Article | Follow @FierceBiotech
@JohnCFierce: The EuroBiotech report: Ex-Shire exec starts at Cortendo, Innate gets orphan nod, Ablynx trims in preclinical. Story | Follow @JohnCFierce
@EmilyMFierce: Canadian Immunovaccine reports positive preclinical data for Ebola vaccine. More | Follow @EmilyMFierce
> After reportedly swearing off a move to buy out the shares in Chugai it doesn't already own, Roche ($RHHBY) has now agreed to amend their long-standing licensing agreement. Release
> Foster City, CA-based SciClone Pharmaceuticals and its partner BTG announced that the China Food and Drug Administration has approved DC Bead for the embolization of malignant hypervascularized tumors. Release
> BioCryst Pharmaceuticals ($BCRX) has received an additional $2.4 million from the National Institute of Allergy and Infectious Diseases to test its plasma kallikrein inhibitor BCX4430 in nonhuman primates as a treatment for Ebola. Release
Medical Device News
@FierceMedDev: New imaging system uses biomarker to guide brain cancer surgery. More | Follow @FierceMedDev
@VarunSaxena2: Between new Brain project initiative and 2 recent $COV buys + $BSX's buy of Bayer's devices, peripheral devices are officially a thing. | Follow @VarunSaxena2
@MichaelGFierce: Organic nanoparticles offer 'complete package' against cancer: delivery and imaging. Article | Follow @MichaelGFierce
> Bayer's startup accelerator funds five device, healthcare app companies. Story
> Covidien acquires Sapheon ahead of FDA approval for vein adhesive. More
Pharma News
@FiercePharma: Top-read on FierceVaccines yesterday: Does Pfizer still need AstraZeneca's vaccines business? Story | Follow @FiercePharma
@EricPFierce: CPhI Worldwide will host #CPhIChat to debate the future of pharma for those of you who want a piece of that. Release | Follow @EricPFierce
@CarlyHFierce: Pfizer's C. diff vaccine gains on Sanofi with FDA fast-track nod. Story | Follow @CarlyHFierce
> Takeda and Lilly remain on the hook for $9B Actos award. More
> FDA says Aegerion has satisfied its demands over chatty CEO. Article